Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ironwood Pharmaceuticals, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient is 18 years of age or older
Patient meets colonoscopy requirements according to the American Gastroenterological Association
Patient meets criteria for chronic constipation including weekly bowel movement frequency requirements and reports one or more symptoms of constipation according to protocol requirements
Patient has successfully completed study requirements with no clinically-significant findings: physical exam, ECG, clinical laboratory tests
Patient is fluent in English
You may not be if
Patient reports loose or watery stools
Patient meets criteria for IBS including protocol-defined abdominal discomfort or pain
Patient may not take prohibited medications per protocol
Medical diagnoses, medical conditions, or family history that would not make the patient a good candidate for the study or limit the patient's ability to complete the clinical study
Clareo Health | Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
